Suppr超能文献

人类 Gb3/CD77 合酶上的两个 N-聚糖中的一个对于其活性是必需的,并通过变构调节其功能。

One of the two N-glycans on the human Gb3/CD77 synthase is essential for its activity and allosterically regulates its function.

机构信息

Laboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla St. 12, 53-114, Wroclaw, Poland.

Department of Theoretical Biophysics, Max Planck Institute for Biophysics, 60438 Frankfurt Am Main, Germany; Faculty of Physics, University of Vienna, 1090, Vienna, Austria.

出版信息

Biochem Biophys Res Commun. 2022 Aug 20;617(Pt 1):36-41. doi: 10.1016/j.bbrc.2022.05.085. Epub 2022 May 31.

Abstract

N-glycosylation is a posttranslational modification that influences many protein properties, such as bioactivity, folding or solubility. The same principles apply to key enzymes in glycosylation pathways, including glycosyltransferases, that also undergoing N-glycosylation, changes in which may affect their activity. Human Gb3/CD77 synthase (encoded by A4GALT) is a Golgi-resident glycosyltransferase, which catalyzes the synthesis of Galα1→4Gal disaccharide on glycosphingolipid- and glycoprotein-derived acceptors, creating Gb3 or P1 antigens and P1 glycotopes (Galα1→4Galβ1→4GlcNAc-R), respectively. The molecules that contain Galα1→4Gal serve as receptors for pathogens and Shiga toxins, which are the major virulence factors of Shiga toxin-producing Escherichia coli (STEC). Human Gb3/CD77 synthase contains two N-glycosylation sites at positions N and N. Using the recombinant soluble glycovariants of human Gb3/CD77 synthase with mutated N-glycosylation sequons expressed in HEK293E cells, we show that the glycovariants devoid of N-glycan at position N or simultaneously at N and N sites reveal no enzymatic activity. In contrast, the N-glycan at position N plays a negligible role, whereas the presence of both N-glycans is required for efficient secretion of the enzyme. Moreover, utilizing specific glycosidases, we have found that the fully N-glycosylated enzyme contains one complex and one hybrid/oligomannose N-glycan, while single mutants contain only the complex type. Finally, in silico analysis using the AlphaFold enzyme model showed that N-glycan attached to N sequon is located in a protein motif near the active site and may allosterically influence the activity. All these findings highlight the prerequisite role of N-glycosylation in human Gb3/CD77 synthase activity (N sequon) and solubility (both N and N), with a particularly prominent role of N-glycan at position N in the regulation of enzyme activity.

摘要

N-糖基化是一种影响许多蛋白质性质的翻译后修饰,如生物活性、折叠或溶解度。糖苷酶在糖基化途径中也是如此,包括糖基转移酶,它们也经历 N-糖基化,其变化可能影响它们的活性。人 Gb3/CD77 合酶(由 A4GALT 编码)是一种驻留在高尔基体的糖基转移酶,它催化半乳糖α 1→4 半乳糖二糖在糖脂和糖蛋白衍生受体上的合成,分别产生 Gb3 或 P1 抗原和 P1 糖基表位(Galα1→4Galβ1→4GlcNAc-R)。含有 Galα1→4Gal 的分子是病原体和志贺毒素的受体,志贺毒素是产志贺毒素大肠杆菌(STEC)的主要毒力因子。人 Gb3/CD77 合酶在位置 N 和 N 含有两个 N-糖基化位点。使用在 HEK293E 细胞中表达的具有突变 N-糖基化序列的重组可溶性糖变体,我们表明,缺乏位置 N 或同时缺乏位置 N 和 N 位点的 N-聚糖的糖变体没有酶活性。相比之下,位置 N 的 N-聚糖起着微不足道的作用,而两种 N-聚糖的存在对于酶的有效分泌是必需的。此外,利用特定的糖苷酶,我们发现完全 N-糖基化的酶含有一个复杂的和一个杂合/寡甘露糖 N-聚糖,而单突变体只含有复杂的类型。最后,使用 AlphaFold 酶模型进行的计算机分析表明,与 N 序列连接的 N-聚糖位于靠近活性位点的蛋白质模体中,并且可以变构地影响活性。所有这些发现都强调了 N-糖基化在人 Gb3/CD77 合酶活性(N 序列)和溶解度(N 和 N)中的前提作用,位置 N 的 N-聚糖在调节酶活性方面具有特别突出的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验